Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Radient Pharmaceuticals' China-Based Subsidiary Jade Pharmaceuticals Signs Letter of Intent to Acquire Shanxi Baotai Pharmaceutical Co. Ltd.
Radient Pharmaceuticals' China-Based Subsidiary Jade Pharmaceuticals Signs Letter of Intent to Acquire Shanxi Baotai Pharmaceutical Co. Ltd.
Radient Pharmaceuticals' China-Based Subsidiary Jade Pharmaceuticals Signs Letter of Intent to Acquire Shanxi Baotai Pharmaceutical Co. Ltd.
Submitted by
moderatora
on July 28, 2010 - 10:48am
Source:
Mass Device
News Tags:
Radient Pharmaceuticals
Jade Pharmaceuticals
China
Shanxi Baotai Pharmaceutical Co.
Headline:
Radient Pharmaceuticals' China-Based Subsidiary Jade Pharmaceuticals Signs Letter of Intent to Acquire Shanxi Baotai Pharmaceutical Co. Ltd.
Do Not Allow Advertisers to Use My Personal information
